Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

NCT03206671 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Mature B-cell Non-Hodgkin Lymphoma

Interventions

DRUG: Rituximab window
DRUG: Additional doses of Rituximab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin hydrochloride
DRUG: Vindesine Sulfate
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Methotrexate
DRUG: Prednisolone
DRUG: Vincristine

Sponsor

University Hospital Muenster

Collaborators

[object Object]